Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia.

Hematological oncology - 1 Apr 2022

Liao Xiong-Yu, Fang Jian-Pei, Zhou Dun-Hua, Qiu Kun-Yin

Abstract excerpt

To evaluate the outcome and prognostic significance of CEBPA mutations among pediatric acute myeloid leukemia (AML) from TARGET dataset. A total of 1803 pediatric patients who were diagnosed with AML were classified into two groups based on the CEBPA status by using a retrospective cohort study method from September 1996 to December 2016. The incidence of CEBPA mutations was 18%. CEBPA mutations were...

Topics

Join the communities discussing this publication.

Acute Myeloid Leukemia Research
Aged
CCAAT-Enhancer-Binding Proteins
Child
Leukemia, Myeloid, Acute

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34816468
DOI: 10.1002/hon.2951

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CEBPA are independent good prognostic factors in pediatric acute myeloid leukemia.PMID 34816468Read ↗

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology GroupSemantic proximity Read ↗

‘Acute myeloid leukemia: a comprehensive review and 2016 update’Semantic proximity Read ↗

Laboratory evaluation and prognostication among adults and children with CEBPA-mutant acute myeloid leukemia.Semantic proximity Read ↗

NPM1, FLT3 and CEBPA mutations in pediatric patients with AML from Argentina: incidence and prognostic value.Semantic proximity Read ↗

Prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group.Semantic proximity Read ↗

A Review in Childhood Acute Myeloid Leukemia: Diagnosis and Novel TreatmentSemantic proximity Read ↗

[Type of CEBPA mutations in acute myeloid leukemia and their effect on prognosis].Semantic proximity Read ↗

[Clinical features and prognostic factors in adult acute myeloid leukemia patients with FLT3-ITD and CEBPA gene co-mutation].Semantic proximity Read ↗

Mutations in the bZip region of the CEBPA gene: A novel prognostic factor in patients with acute myeloid leukemia.Semantic proximity Read ↗

[Recent Advances of Research on CEBPA Mutation in Acute Myeloid Leukemia].Semantic proximity Read ↗

Prognosis and treatment in acute myeloid leukemia: a comprehensive reviewSemantic proximity Read ↗

Acute Myeloid Leukemia With CEBPA Mutations: Current Progress and Future DirectionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.